A citation-based method for searching scientific literature

Women's Benefits and Harms Trade-Offs in Breast Cancer Screening: Results from a Discrete-Choice Experiment.
Jonathan Sicsic, Nathalie Pelletier-Fleury, Nora Moumjid. Value Health 2018
Times Cited: 19






Login to export Results
Don't have an account? Register here

List of co-cited articles
85 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Benefits and harms of mammography screening.
Magnus Løberg, Mette Lise Lousdal, Michael Bretthauer, Mette Kalager. Breast Cancer Res 2015
145
4
21

Investigating the Heterogeneity in Women's Preferences for Breast Screening: Does the Communication of Risk Matter?
Caroline M Vass, Dan Rigby, Katherine Payne. Value Health 2018
14
4
28

Sample Size Requirements for Discrete-Choice Experiments in Healthcare: a Practical Guide.
Esther W de Bekker-Grob, Bas Donkers, Marcel F Jonker, Elly A Stolk. Patient 2015
316
4
21

Stated Preference for Cancer Screening: A Systematic Review of the Literature, 1990-2013.
Carol Mansfield, Florence K L Tangka, Donatus U Ekwueme, Judith Lee Smith, Gery P Guy, Chunyu Li, A Brett Hauber. Prev Chronic Dis 2016
51
4
21

Conjoint analysis applications in health--a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force.
John F P Bridges, A Brett Hauber, Deborah Marshall, Andrew Lloyd, Lisa A Prosser, Dean A Regier, F Reed Johnson, Josephine Mauskopf. Value Health 2011
997
3
15

The benefits and harms of breast cancer screening: an independent review.
M G Marmot, D G Altman, D A Cameron, J A Dewar, S G Thompson, M Wilcox. Br J Cancer 2013
522
3
15

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
44702
3
15

Assessing stated preferences for colorectal cancer screening: a critical systematic review of discrete choice experiments.
S Wortley, G Wong, A Kieu, K Howard. Patient 2014
34
3
15

Summary of the evidence of breast cancer service screening outcomes in Europe and first estimate of the benefit and harm balance sheet.
Eugenio Paci. J Med Screen 2012
130
3
15

Recommendations on screening for breast cancer in women aged 40-74 years who are not at increased risk for breast cancer.
Scott Klarenbach, Nicki Sims-Jones, Gabriela Lewin, Harminder Singh, Guylène Thériault, Marcello Tonelli, Marion Doull, Susan Courage, Alejandra Jaramillo Garcia, Brett D Thombs. CMAJ 2018
95
3
15

Statistical Methods for the Analysis of Discrete Choice Experiments: A Report of the ISPOR Conjoint Analysis Good Research Practices Task Force.
A Brett Hauber, Juan Marcos González, Catharina G M Groothuis-Oudshoorn, Thomas Prior, Deborah A Marshall, Charles Cunningham, Maarten J IJzerman, John F P Bridges. Value Health 2016
505
3
15

Discrete Choice Experiments in Health Economics: Past, Present and Future.
Vikas Soekhai, Esther W de Bekker-Grob, Alan R Ellis, Caroline M Vass. Pharmacoeconomics 2019
248
3
15

Public Preferences and Predicted Uptake for Esophageal Cancer Screening Strategies: A Labeled Discrete Choice Experiment.
Yonne Peters, Peter D Siersema. Clin Transl Gastroenterol 2020
7
3
42

Colorectal Cancer Screening: Preferences, Past Behavior, and Future Intentions.
Carol Mansfield, Donatus U Ekwueme, Florence K L Tangka, Derek S Brown, Judith Lee Smith, Gery P Guy, Chunyu Li, Brett Hauber. Patient 2018
13
3
23

Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.
Kyriaki Michailidou, Jonathan Beesley, Sara Lindstrom, Sander Canisius, Joe Dennis, Michael J Lush, Mel J Maranian, Manjeet K Bolla, Qin Wang, Mitul Shah,[...]. Nat Genet 2015
379
2
10

Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model.
Jeffrey A Tice, Steven R Cummings, Rebecca Smith-Bindman, Laura Ichikawa, William E Barlow, Karla Kerlikowske. Ann Intern Med 2008
362
2
10

Constructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force.
F Reed Johnson, Emily Lancsar, Deborah Marshall, Vikram Kilambi, Axel Mühlbacher, Dean A Regier, Brian W Bresnahan, Barbara Kanninen, John F P Bridges. Value Health 2013
781
2
10

Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk Prediction.
Elke M van Veen, Adam R Brentnall, Helen Byers, Elaine F Harkness, Susan M Astley, Sarah Sampson, Anthony Howell, William G Newman, Jack Cuzick, D Gareth R Evans. JAMA Oncol 2018
69
2
10

A breast cancer prediction model incorporating familial and personal risk factors.
Jonathan Tyrer, Stephen W Duffy, Jack Cuzick. Stat Med 2004
717
2
10

A qualitative study on Singaporean women's views towards breast cancer screening and Single Nucleotide Polymorphisms (SNPs) gene testing to guide personalised screening strategies.
Xin Yi Wong, Kok Joon Chong, Janine A van Til, Hwee Lin Wee. BMC Cancer 2017
12
2
16

The WISDOM Study: breaking the deadlock in the breast cancer screening debate.
Laura J Esserman. NPJ Breast Cancer 2017
124
2
10

Public stated preferences and predicted uptake for genome-based colorectal cancer screening.
Catharina G M Groothuis-Oudshoorn, Jilles M Fermont, Janine A van Til, Maarten J Ijzerman. BMC Med Inform Decis Mak 2014
17
2
11

A systematic assessment of benefits and risks to guide breast cancer screening decisions.
Lydia E Pace, Nancy L Keating. JAMA 2014
265
2
10

The effect of including an opt-out option in discrete choice experiments.
Jorien Veldwijk, Mattijs S Lambooij, Esther W de Bekker-Grob, Henriëtte A Smit, G Ardine de Wit. PLoS One 2014
71
2
10

Systematic reviews as a 'lens of evidence': Determinants of benefits and harms of breast cancer screening.
Olena Mandrik, Nadine Zielonke, Filip Meheus, J L Hans Severens, Neela Guha, Rolando Herrero Acosta, Raul Murillo. Int J Cancer 2019
30
2
10

Breast Cancer Knowledge, Behaviors, and Preferences in Malawi: Implications for Early Detection Interventions From a Discrete Choice Experiment.
Racquel E Kohler, Satish Gopal, Clara N Lee, Bryan J Weiner, Bryce B Reeve, Stephanie B Wheeler. J Glob Oncol 2017
14
2
14

Preferences for colorectal cancer screening strategies: a discrete choice experiment.
L Hol, E W de Bekker-Grob, L van Dam, B Donkers, E J Kuipers, J D F Habbema, E W Steyerberg, M E van Leerdam, M L Essink-Bot. Br J Cancer 2010
65
2
10

Attribute level overlap (and color coding) can reduce task complexity, improve choice consistency, and decrease the dropout rate in discrete choice experiments.
Marcel F Jonker, Bas Donkers, Esther de Bekker-Grob, Elly A Stolk. Health Econ 2019
34
2
10

People's willingness to accept overdetection in cancer screening: population survey.
Ann Van den Bruel, Caroline Jones, Yaling Yang, Jason Oke, Paul Hewitson. BMJ 2015
28
2
10

Systematic review: the long-term effects of false-positive mammograms.
Noel T Brewer, Talya Salz, Sarah E Lillie. Ann Intern Med 2007
305
2
10

Benefits and Harms of Breast Cancer Screening: A Systematic Review.
Evan R Myers, Patricia Moorman, Jennifer M Gierisch, Laura J Havrilesky, Lars J Grimm, Sujata Ghate, Brittany Davidson, Ranee Chatterjee Mongtomery, Matthew J Crowley, Douglas C McCrory,[...]. JAMA 2015
310
2
10

Women's misconceptions about cancer screening: implications for informed decision-making.
Thomas D Denberg, Sabrina Wong, Angela Beattie. Patient Educ Couns 2005
39
2
10

Mammographic screening programmes in Europe: organization, coverage and participation.
Livia Giordano, Lawrence von Karsa, Mariano Tomatis, Ondrej Majek, Chris de Wolf, Lesz Lancucki, Solveig Hofvind, Lennarth Nyström, Nereo Segnan, Antonio Ponti,[...]. J Med Screen 2012
118
2
10

Screening for breast cancer with mammography.
Peter C Gøtzsche, Margrethe Nielsen. Cochrane Database Syst Rev 2011
240
2
10

Breast cancer screening in an era of personalized regimens: a conceptual model and National Cancer Institute initiative for risk-based and preference-based approaches at a population level.
Tracy Onega, Elisabeth F Beaber, Brian L Sprague, William E Barlow, Jennifer S Haas, Anna N A Tosteson, Mitchell D Schnall, Katrina Armstrong, Marilyn M Schapira, Berta Geller,[...]. Cancer 2014
97
2
10

Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests.
Andrew J Vickers, Ben Van Calster, Ewout W Steyerberg. BMJ 2016
418
2
10

Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial.
Jolyn Hersch, Alexandra Barratt, Jesse Jansen, Les Irwig, Kevin McGeechan, Gemma Jacklyn, Hazel Thornton, Haryana Dhillon, Nehmat Houssami, Kirsten McCaffery. Lancet 2015
183
2
10

The benefits and harms of breast cancer screening: an independent review.
. Lancet 2012
869
2
10

Individual decision making about lung cancer screening: A conjoint analysis of perspectives among a high-risk national sample.
Margaret M Byrne, Richard J Thurer, Jamie L Studts. Cancer Med 2019
6
2
33

Enthusiasm for cancer screening in the United States.
Lisa M Schwartz, Steven Woloshin, Floyd J Fowler, H Gilbert Welch. JAMA 2004
493
2
10

Guidance for updating clinical practice guidelines: a systematic review of methodological handbooks.
Robin W M Vernooij, Andrea Juliana Sanabria, Ivan Solà, Pablo Alonso-Coello, Laura Martínez García. Implement Sci 2014
105
2
10

Guidelines for early detection of breast cancer in Brazil. III - Challenges for implementation.
Arn Migowski, Maria Beatriz Kneipp Dias, Paulo Nadanovsky, Gulnar Azevedo E Silva, Denise Rangel Sant'Ana, Airton Tetelbom Stein. Cad Saude Publica 2018
10
2
20

The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines.
Melissa C Brouwers, Kate Kerkvliet, Karen Spithoff. BMJ 2016
311
2
10

A Reporting Tool for Practice Guidelines in Health Care: The RIGHT Statement.
Yaolong Chen, Kehu Yang, Ana Marušic, Amir Qaseem, Joerg J Meerpohl, Signe Flottorp, Elie A Akl, Holger J Schünemann, Edwin S Y Chan, Yngve Falck-Ytter,[...]. Ann Intern Med 2017
271
2
10

Shared decision making in breast cancer treatment guidelines: Development of a quality assessment tool and a systematic review.
Marta Maes-Carballo, Isabel Muñoz-Núñez, Manuel Martín-Díaz, Luciano Mignini, Aurora Bueno-Cavanillas, Khalid Saeed Khan. Health Expect 2020
15
2
13

Breast Cancer Screening in 2018: Time for Shared Decision Making.
Nancy L Keating, Lydia E Pace. JAMA 2018
42
2
10

Implications of Overdiagnosis: Impact on Screening Mammography Practices.
Elizabeth Morris, Stephen A Feig, Madeline Drexler, Constance Lehman. Popul Health Manag 2015
42
2
10

A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research.
Terry K Koo, Mae Y Li. J Chiropr Med 2016
8178
2
10

Practice Bulletin Number 179: Breast Cancer Risk Assessment and Screening in Average-Risk Women.
. Obstet Gynecol 2017
97
2
10

Shared decision making--pinnacle of patient-centered care.
Michael J Barry, Susan Edgman-Levitan. N Engl J Med 2012
1794
2
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.

Longstocking, LLC. © 2021
Home | About Us | FAQs | Terms & Privacy